#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study of donidalorsen for children with hereditary angioedema

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy Poland Spain

  • A study of navenibart for long-term safety in patients with hereditary angioedema

    Recruiting

    3 1
    Investigated Drugs:
    Austria Bulgaria Czechia France Germany Hungary +5

  • A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +5

  • Study of deucrictibant tablets for prevention of hereditary angioedema attacks in adults and adolescents

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Bulgaria France Germany Hungary Ireland +5

  • Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Italy Poland Slovakia +1

  • Study on C1 Esterase Inhibitor for Treating and Preventing Hereditary Angioedema Attacks in Patients with C1-INH Deficiency

    Recruiting

    3 1 1
    Investigated Drugs:
    Bulgaria Romania

  • Long-Term Safety Study of NTLA-2002 for Patients with Hereditary Angioedema, Using Messenger RNA Encoding Cas9 and HU-G012267

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands

  • Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia France +5

  • Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Czechia France Germany Hungary +5

  • Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema

    Not recruiting

    3 1 1
    Investigated Drugs:
    Germany